Study to Evaluate Safety, Efficacy of Botulinum Toxin Type A in Patients With Cervical Dystonia

Completed · Phase 2 · Has a placebo group

Conditions studied: Cervical Dystonia

In brief

Study is to investigate the use of the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) scale in a cervical dystonia population treated with botulinum toxin type A, and placebo.

Key facts

Study ID

NCT00564681

Run by

Allergan

People needed

242

Starts

2007-12-01

Expected to finish

2009-12-01

Last updated by the study team

2016-01-05

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of cervical dystonia

You may not qualify if…

• Current or previous botulinum toxin treatment of any type for any condition

Where it is running

• Study site — Winston-Salem, North Carolina, United States
• Study site — Halifax, Nova Scotia, Canada
• Study site — Prague, Czechia
• Study site — Berlin, Germany
• Study site — Budapest, Hungary
• Study site — Mumbai, India
• Study site — Manila, Philippines
• Study site — Warsaw, Poland
• Study site — Moscow, Russia
• Study site — Belgrade, Serbia
• Study site — Singapore, Singapore
• Study site — Spisska Nova, Slovakia
• Study site — Cape Town, South Africa
• Study site — Tainan, Taiwan
• Study site — Bangkok, Thailand
• Study site — Bristol, United Kingdom

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.